Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function

Kidney International

Volumn 73, Issue 7, 2008, Pages 877-884

  Aquino Dias, E C ^a   Joelsons, G ^b   Da Silva, D M ^b   Berdichewski, R H ^b   Ribeiro, A R ^b   Veronose, F J V ^a,b   Goncalves L F ^a,b   Manfro, R C ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Acute rejection; Delayed graft function; Fas ligand; FOXP3; Kidney transplantation; Perforin

Indexed keywords

FAS LIGAND; GRANZYME B; PERFORIN; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR 9; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DELAYED GRAFT FUNCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SENSITIVITY AND SPECIFICITY;

EID: 40849097609     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002795     Document Type: Article

References (40)

1. Meier-Kriesche HU, Schold JD, Srinivas TR et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-783.
2. Cosio FG, Pelletier RP, Falkenhain ME et al. Impact of acute rejection and early allograft function on renal allograft survival. Transplantation 1997; 63: 1611-1615.
3. Ojo AO, Wolfe RA, Held PJ et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968-974.
4. Perico N, Cattaneo D, Sayegh MH et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827.
5. Szwarc I, Garrigue V, Delmas S et al. Delayed graft function: a frequent but still unsolved problem in renal transplantation. Nephrol Ther 2005; 1: 325-334.
6. Johnston O, O'Kelly P, Spencer S et al. Reduced graft function (with or without dialysis) vs immediate graft function: a comparison of long-term renal allograft survival. Nephrol Dial Transplant 2006; 21: 2270-2274.
7. Chapman J, Bock A, Dussol B et al. Follow-up after renal transplantation with organs from donors after cardiac death. Transpl Int 2006; 19: 715-719.
8. Geddes CC, Woo YM, Jardine AG. The impact of delayed graft function on the long-term outcome of renal transplantation. J Nephrol 2002; 15: 17-21.
9. Sharma VK, Bologa RM, Li B et al. Molecular executors of cell death: differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation 1996; 62: 1860-1866.
10. Strehlau J, Pavlakis M, Lipman M et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695-700.
11. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120-5127.
12. Vasconcellos LM, Schachter AD, Zheng XX et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998; 66: 562-566.
13. Kirk AD, Jacobson LM, Heisey DM et al. Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function. Transplantation 1999; 68: 1578-1582.
14. Aquino-Dias EC, Veronese FJ, Goncalves LFS et al. Molecular markers in subclinical acute rejection of renal transplants. Clin Transplant 2004; 18: 281-287.
15. Sabek O, Dorak MT, Kotb M et al. Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation 2002; 74: 701-707.
16. Desvaux D, Schwarzinger M, Pastural M et al. Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance. Transplantation 2004; 78: 647-653.
17. Kotsch K, Mashreghi MF, Bold G et al. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation 2004; 77: 1866-1875.
18. Simon T, Opelz G, Wiesel M et al. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003; 3: 1121-1127.
19. Hoffmann SC, Hale DA, Kleiner DE et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005; 5: 573-581.
20. Bladergroen BA, Strik MC, Bovenschen N et al. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J Immunol 2001; 166: 3218-3225.
21. Muthukumar T, Ding R, Dadhania D et al. Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation 2003; 75: 1565-1570.
22. Rowshani AT, Florquin S, Bemelman F et al. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection. Kidney Int 2004; 66: 1417-1422.
23. Muthukumar T, Dadhania D, Ding R et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342-2351.
24. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
25. Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947-954.
26. Nickel P, Lacha J, Ode-Hakim S et al. Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft. Transplantation 2001; 72: 1158-1160.
27. Ding R, Li B, Muthukumar T et al. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation 2003; 75: 1307-1312.
28. Dadhania D, Muthukumar T, Ding R et al. Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection. Transplantation 2003; 75: 1752-1754.
29. Dresske B, Haendschke F, Lenz P et al. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients. Transplantation 2006; 81: 1549-1557.
30. Strom TB, Suthanthiran M. Transcriptional profiling to assess the clinical status of kidney transplants. Nat Clin Pract Nephrol 2006; 2: 116-117.
31. Morgan ME, van Bilsen JH, Bakker AM et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005; 66: 13-20.
32. Gavin MA, Torgerson TR, Houston E et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006; 103: 6659-6664.
33. Tatapudi RR, Muthukumar T, Dadhania D et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int 2004; 65: 2390-2397.
34. Matz M, Beyer J, Wunsch D et al. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int 2006; 69: 1683-1690.
35. Yannaraki M, Rebibou JM, Ducloux D et al. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl Int 2006; 19: 759-768.
36. Gibbs PJ, Tan LC, Sadek SA et al. Quantitative detection of changes in cytokine gene expression in peripheral blood mononuclear cells correlates with and precedes acute rejection in renal transplant recipients. Transpl Immunol 2005; 14: 99-108.
37. Graziotto R, Del Prete D, Rigotti P et al. Perforin, granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues. Transplantation 2006; 81: 1125-1132.
38. Medeiros M, Sharma VK, Ding R et al. Optimization of RNA yield, purity and mRNA copy number by treatment of urine cell pellets with RNAlater. J Immunol Methods 2003; 279: 135-142.
39. -ΔΔCT method. Methods 2001; 25: 402-408.
40. Kirkwood BR, Sterne JAC. Essential Medical Statistics, 2nd edn. Malden, Blackwell Science Ltd, 2003, 501pp.